3D-Printed Organs Market

The Global 3D-Printed Organs Market was valued USD 2.13 Billion in 2023 and projected to reach USD 2.99 Billion by 2030, growing at a CAGR of 18.51% during the forecast period of 2023-2030.

According to a research report "3D-Printed Organs Market, by Organ Type (Heart, Liver, Kidney, Lung, Skin, Bone, Pancreas, Ear, Eye and Others), Technology (Extrusion-Based 3D Printing, Laser-Assisted Printing, Inkjet Printing, Stereolithography, Magnetic Levitation, Laser Based and Others), Material Type (Biological Materials (Bioinks), Synthetic Polymers, Hydrogels, Ceramics, Metals and Biomaterials), Application (Transplantation, Research & Drug Testing, Disease Modeling, Regenerative Medicine and Medical Training & Education), End-user (Hospitals & Clinics, Research Institutes & Laboratories, Pharmaceutical Companies, Academic Institutions and Others) & Region.

Download the Sample - https://www.marketdigits.com/request/sample/115

• 160 - Market Data Tables
• 61 - List of Figures
• 210 - Pages

Market Overview

The market for 3D-printed organs signifies a groundbreaking progression at the convergence of biotechnology, medical science, and additive manufacturing. This domain revolves around harnessing 3D printing technology to fabricate fully operational human organs, employing a method that constructs layer upon layer while adhering to the principles of regenerative medicine. The substantial growth of the 3D-printed organs market is substantially attributed to the widespread occurrence of chronic illnesses. Moreover, heightened utilization and deployment of 3D organs, coupled with an aging demographics inclined toward medical procedures is anticipated to bolster the overall market expansion. The mounting research and development endeavors in 3D printing technology, coupled with governmental investments in pertinent projects, are poised to unveil novel prospects for market advancement. However, the creation of 3D-printed organs can entail considerable costs due to the specialized apparatus, materials, and expertise involved. Ensuring the compatibility of bio-inks and materials to avoid immune responses remains a pivotal challenge.

Major Players covered in the Global 3D-Printed Organs Market:

• Organovo Holdings Inc.
• Modern Meadow
• Poietis
• REGEMAT 3D S.L.
• Cellbricks
• Nano3D Biosciences Inc.
• Medprin Regenerative Medical Technologies Co.Ltd
• EnvisionTEC
• nScrypt
• Advanced Solutions, Inc.
• Digilab Inc.
• TeVido BioDevices
• Aspect Biosystems Ltd.
• Cyfuse Biomedical K.K.
• CELLINK GLOBAL
• 3D Systems
• BioBots
• Rokit Healthcare
• Tissue Regenix Group
• LIFE 3D

Market Dynamics

Drivers:

• Increasing geriatric population with chronic respiratory diseases
• Advances in 3D printing technology
• Development of new bioinks

Opportunities:

• Improvement of 3D printing techniques
• Advancements in Biomaterials

The market for 3D-printed organs is dominated by North America.

In 2023, North America takes the lead in the 3D-printed organs market, trailed by Europe and Asia-Pacific. The North American region is characterized by a heightened incidence of chronic ailments like heart disease, cancer, and diabetes. These conditions often culminate in organ failure, significantly propelling the demand for 3D-printed organs. Substantial investments from both governmental bodies and private organizations in North America are channeled into the research and development of 3D-printed organs. Consequently, this momentum fuels the emergence of novel and advanced 3D printing technologies, facilitating the creation of intricate and lifelike organs. In the realm of North American 3D-printed organs, prominent players such as Organovo Holdings, Inc., RegenHU, Inc., and 3D Bioprinting Solutions, Inc., hold sway. These entities commit substantial resources to research and development endeavors, propelling innovation and ushering innovative products into the market.

Asia-Pacific is poised to undergo swift expansion within the 3D-printed organs market. Demonstrating an exceptional propensity for embracing novel technologies, the region is adept at rapidly assimilating innovations. This predisposition positions the area favorably to harness advancements in 3D printing, particularly in the realm of organ fabrication. The region's densely populated and diverse demographics provides an extensive reservoir of potential patients for organ transplants. This substantial recipient pool fosters a heightened demand for forward-looking solutions like 3D-printed organs. Furthermore, numerous countries in Asia-Pacific have made remarkable advancements in medical research and healthcare innovation. The synergy of medical expertise with cutting-edge 3D printing technology is expected to expedite both the development and adoption of 3D-printed organs. In light of these factors, it is anticipated that Asia-Pacific will observe a notable upswing in research, developmental initiatives, and the incorporation of 3D-printed organs in the years to come. This trajectory is poised to significantly contribute to the accelerated expansion of the market across the region.

Direct Buy: @ https://www.marketdigits.com/checkout/115

Recent Developments

In May 2023, Bioprinting Solutions announced that it had partnered with the University of California, San Francisco to develop 3D-printed heart tissue. The partnership will use the university's expertise in heart disease to develop tissue that can be used to repair damaged hearts.

About MarketDigits:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

Contact Us: Email: sales@marketdigits.com